CDKN2A and type 2 diabetes mellitus: Understanding how Cdkn2a can relay to initiate a thermogenic program in hiPSC-BAPs is a first step to envisage activating beiging as a new putative therapy to alleviate the effects of obesity and to prevent insulin resistance and T2D.